Cargando…
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV‐associated lymphoproliferative disease
OBJECTIVES: Increasing evidence indicates that some germline genetic mutations that impair pathways required for robust host immune surveillance against EBV infection may result in an extremely high susceptibility to EBV‐associated lymphoproliferative disease (EBV(+) LPD). TNFRSF9 encodes a vital co...
Autores principales: | Shen, Kefeng, Wang, Jiachen, Zhou, Kuangguo, Mu, Wei, Zhang, Meilan, Deng, Xinyue, Cai, Haodong, Zhang, Wei, Huang, Wei, Xiao, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153300/ https://www.ncbi.nlm.nih.gov/pubmed/37144041 http://dx.doi.org/10.1002/cti2.1448 |
Ejemplares similares
-
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes
por: Pulvirenti, Federica, et al.
Publicado: (2016) -
CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
por: Hashimoto, Kenji
Publicado: (2021) -
ADA2 deficiency complicated by EBV-driven lymphoproliferative disease
por: Staples, Emily, et al.
Publicado: (2020) -
Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022) -
CD137-CD137L Interaction Regulates Atherosclerosis via Cyclophilin A in Apolipoprotein E-Deficient Mice
por: Li, Yuefeng, et al.
Publicado: (2014)